Benefits
Dopamine-mediated antidepressant-like mechanism
In mice and rats, a bark extract shortened immobility in the forced swim test, a standard animal screen for antidepressant-like activity. In laboratory dishes it slowed dopamine reuptake and increased dopamine release from rat brain tissue, with smaller effects on serotonin. This is animal and test tube work only. No human trial has tested catuaba for mood, so it is not known whether any of this happens in people, and catuaba is not a treatment for depression.
Catuama® combination preclinical evidence
Catuama® is a Brazilian commercial combination of T. catigua + Paullinia cupana (guaraná) + Zingiber officinale (ginger) + Ptychopetalum olacoides (muirapuama). The evidence for this blend is preclinical: animal and laboratory work, including blood vessel relaxation in tissue experiments at a very high concentration (EC50 about 1,073 micrograms per mL). The one human study of Catuama was a 28 day safety check in healthy volunteers taking 25 mL twice a day, and it looked for side effects and blood chemistry changes rather than benefits. Because four herbs were given together, nothing from this work can be credited to catuaba on its own.
Antifatigue and memory effects (preclinical)
A 2018 study in adult male mice and rats reported antioxidant, cholinesterase-inhibiting and antifatigue effects at doses of 25 to 300 mg per kilogram of body weight. Those are animal doses well above what people take, and no human study has tested catuaba for energy or memory.
Registered depression trial with no results yet
A Brazilian trial in people with a depressive episode has been registered. No results have been published, so it provides no evidence in either direction today. A registered trial is a plan, not a finding.
Aphrodisiac and sexual function (traditional + preclinical)
Catuaba's reputation as an aphrodisiac comes from traditional Brazilian use, not from trials. The supporting laboratory work is limited to animal and isolated tissue experiments. No human study has tested catuaba for libido, erections or any other measure of sexual function, so the herb's most popular use is also its least tested one.
Anti-inflammatory and neuroprotective (preclinical)
Animal and laboratory studies report anti-inflammatory, pain-reducing and nerve-protective signals, thought to come from the bark's polyphenols (flavalignans, catechins and proanthocyanidins). None of this has been tested in people, and it is not evidence that catuaba reduces inflammation, relieves pain or protects the brain.
Mechanism of action
Dopamine reuptake inhibition + release increase (primary mechanism)
In experiments on nerve endings isolated from rat brains, the extract slowed dopamine reuptake and increased dopamine release, more so at higher concentrations. This is a laboratory finding in rat tissue. Whether it changes dopamine in the human brain has never been tested, and catuaba is not a treatment for depression or a substitute for prescribed antidepressants.
Serotonin reuptake inhibition (secondary)
A weaker effect on serotonin reuptake showed up in the same rat tissue experiments. Nothing about this has been measured in people, but on that theoretical basis anyone taking an SSRI or SNRI antidepressant should speak with their prescriber before using catuaba.
Anticholinesterase activity (memory mechanism)
In animal and test tube work the extract slowed the enzyme that breaks down acetylcholine, a brain chemical involved in memory. No human study has shown this improves memory, and the comparison to prescription memory medicines is not warranted.
NO-mediated vascular relaxation
In isolated blood vessel experiments, the four herb Catuama blend relaxed vessels through the nitric oxide pathway, but only at a very high concentration (EC50 about 1,073 micrograms per mL). That is a tissue bath result for a mixture of four herbs, not a demonstrated effect on human circulation or sexual function.
Antioxidant via polyphenol matrix
Flavalignans (cinchonain Ia, Ib, IIa, IIb), flavan-3-ols (catechin, epicatechin), and proanthocyanidins together provide a broad antioxidant matrix. Cinchonain flavalignans are the most distinctive compound class for T. catigua.
PDE5 inhibition (preclinical sexual function)
Laboratory work suggests some activity on PDE5, an enzyme involved in blood flow. This comes from animal and test tube experiments only, and it should not be read as meaning catuaba works like erectile dysfunction medication.
Clinical trials
Clinical evidence on Catuaba (Trichilia catigua) for the indications and outcomes described.
Clinical population described in trial publication.
Campos MM et al. 2005, Psychopharmacology. This was an animal study, not a clinical trial. Bark extract reduced immobility in the forced swim test in mice and rats, and in rat brain tissue it slowed dopamine reuptake and increased dopamine release, with weaker serotonin effects. No people took part, so it says nothing about mood in humans.
Clinical evidence on Catuaba (Trichilia catigua) for the indications and outcomes described.
Clinical population described in trial publication.
Catuama is a Brazilian product combining T. catigua with guarana, ginger and muirapuama. The laboratory work includes nitric oxide mediated blood vessel relaxation at a high concentration (EC50 about 1,073 micrograms per mL). The only human study of it (Oliveira CH et al. 2005, Phytotherapy Research) was a 28 day toxicology study: healthy volunteers took 25 mL twice daily and researchers watched for adverse reactions and blood chemistry changes, finding none that were severe. That study measured safety, not benefit, and it tested four herbs at once, so no result can be assigned to catuaba.
NCT02532660 LABCAT TCJUSS — Brazilian clinical trial in depressive episode patients, currently recruiting.
Clinical population described in trial publication.
NCT02532660 (LABCAT TCJUSS) is a registered Brazilian trial in people diagnosed with a depressive episode. No results have been published, so there is nothing to report from it. It is listed here for transparency, not as evidence, and a trial in patients with depression would in any case not tell a healthy person what catuaba does for them.